Ingold Karine, Zumsteg Adrian, Tardivel Aubry, Huard Bertrand, Steiner Quynh-Giao, Cachero Teresa G, Qiang Fang, Gorelik Leonid, Kalled Susan L, Acha-Orbea Hans, Rennert Paul D, Tschopp Jürg, Schneider Pascal
Department of Biochemistry, University of Lausanne, CH-1066 Epalinges, Switzerland.
J Exp Med. 2005 May 2;201(9):1375-83. doi: 10.1084/jem.20042309. Epub 2005 Apr 25.
B cell activating factor of the tumor necrosis factor (TNF) family (BAFF) and a proliferation-inducing ligand (APRIL) are closely related ligands within the TNF superfamily that play important roles in B lymphocyte biology. Both ligands share two receptors--transmembrane activator and calcium signal--modulating cyclophilin ligand interactor (TACI) and B cell maturation antigen (BCMA)--that are predominantly expressed on B cells. In addition, BAFF specifically binds BAFF receptor, whereas the nature of a postulated APRIL-specific receptor remains elusive. We show that the TNF homology domain of APRIL binds BCMA and TACI, whereas a basic amino acid sequence (QKQKKQ) close to the NH2 terminus of the mature protein is required for binding to the APRIL-specific "receptor." This interactor was identified as negatively charged sulfated glycosaminoglycan side chains of proteoglycans. Although T cell lines bound little APRIL, the ectopic expression of glycosaminoglycan-rich syndecans or glypicans conferred on these cells a high binding capacity that was completely dependent on APRIL's basic sequence. Moreover, syndecan-1-positive plasma cells and proteoglycan-rich nonhematopoietic cells displayed high specific, heparin-sensitive binding to APRIL. Inhibition of BAFF and APRIL, but not BAFF alone, prevented the survival and/or the migration of newly formed plasma cells to the bone marrow. In addition, costimulation of B cell proliferation by APRIL was only effective upon APRIL oligomerization. Therefore, we propose a model whereby APRIL binding to the extracellular matrix or to proteoglycan-positive cells induces APRIL oligomerization, which is the prerequisite for the triggering of TACI- and/or BCMA-mediated activation, migration, or survival signals.
肿瘤坏死因子(TNF)家族的B细胞活化因子(BAFF)和增殖诱导配体(APRIL)是TNF超家族中密切相关的配体,在B淋巴细胞生物学中发挥重要作用。这两种配体共享两种受体——跨膜激活剂和钙信号调节亲环素配体相互作用分子(TACI)以及B细胞成熟抗原(BCMA),它们主要在B细胞上表达。此外,BAFF特异性结合BAFF受体,而假定的APRIL特异性受体的性质仍然难以捉摸。我们发现,APRIL的TNF同源结构域与BCMA和TACI结合,而与成熟蛋白NH2末端附近的一个碱性氨基酸序列(QKQKKQ)是与APRIL特异性“受体”结合所必需的。这种相互作用分子被鉴定为蛋白聚糖带负电荷的硫酸化糖胺聚糖侧链。尽管T细胞系与APRIL结合很少,但富含糖胺聚糖的多配体聚糖或磷脂酰肌醇蛋白聚糖的异位表达赋予这些细胞高结合能力,这完全依赖于APRIL的碱性序列。此外,多配体聚糖-1阳性浆细胞和富含蛋白聚糖的非造血细胞对APRIL表现出高特异性、肝素敏感的结合。抑制BAFF和APRIL,但不单独抑制BAFF,可阻止新形成的浆细胞存活和/或迁移至骨髓。此外,APRIL对B细胞增殖的共刺激仅在APRIL寡聚化时有效。因此,我们提出了一个模型,即APRIL与细胞外基质或蛋白聚糖阳性细胞结合诱导APRIL寡聚化,这是触发TACI和/或BCMA介导的激活、迁移或存活信号的先决条件。